-
Symbol
-
RNAZ on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
113K shares
-
Security Ownership
-
9.9%
Anson Funds Management LP ownership in Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share (RNAZ)
2025-02-14 - Anson Funds Management LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 113K shares of Transcode Therapeutics, Inc. Common Stock, par value $0.0001 per share (RNAZ).
This represents 9.9% percent ownership of the company.